...
【24h】

Rapid Methods

机译:快速方法

获取原文
获取原文并翻译 | 示例
           

摘要

Recent advances in mycoplasma testing using automated rapid NAT-based methods provide opportunities that can potentially revolutionise quality control and lot release and substantially impact biopharmaceutical manufacturing: Testing for the absence of mycoplasmas is an essential part of quality control (QC) measures in biopharmaceutical production processes. However, the detection of mycoplasmas by traditional culture methods, as required by official regulatory protocols, sometimes poses a major challenge. Hurdles include their small cell size, the wide diversity of species, the cell invasiveness of some species, their special nutrient requirements, the limited generation of turbidity in liquid culture and the non-cu!tivability of some species and strains in standard mycoplasma growth media. Therefore, low-grade mycoplasma contaminations might go unrecognised for a long time, as a number of spectacular mycoplasma contamination cases have previously shown. The often catastrophic consequences are lost production time and considerable revenue losses.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号